Table 2.
Angiographic characteristics of target vessels treated with DCB or DES
| Characteristic | DCB, N = 544 | DES, N = 693 | p value |
|---|---|---|---|
| Vessels treated, n (%) | 0.0062 | ||
| LMS | 15 (2.8) | 27 (3.9) | |
| LAD | 309 (57) | 376 (54) | |
| LCx | 104 (19) | 98 (14) | |
| RCA | 111 (20) | 172 (25) | |
| Graft | 5 (0.9) | 20 (2.9) | |
| Multivessel PCI, n (%) | 51 (9.4) | 83 (12) | 0.142 |
| Patients with true bifurcation disease, n (%) | 63 (12) | 56 (8.1) | 0.0382 |
| Patients with vessel treated ≥ 3 mm | 398 (73) | 594 (86) | < 0.0012 |
| Dual antiplatelet therapy | 518 (95.2%) | 681 (98.3%) | < 0.0022 |
| Duration of dual antiplatelet therapy, Median (IQR) days | 30 (29, 31) | 365 (364, 365) | < 0.0011 |
| Lesions | |||
| De novo lesions treated | DCB (640) | DES (831) | |
| True bifurcation, n (%) | 64 (10) | 55 (6.6) | 0.022 |
| Vessel diameter (mm), Median (IQR) | 3.00 (2.75–3.50) | 3.50 (3.00–3.75) | < 0.0011 |
| Lesion length (mm), median (IQR) | 20 (20–30) | 24 (18–38) | 0.0431 |
| Dissection grade post-DCB [14] | |||
| A | 20 (3.1%) | n/a | |
| B | 278 (43.4%) | n/a | |
| C | 5 (0.8%) | n/a | |
| D | 3 (0.5%) | n/a | |
DCB drug-coated balloon, DES drug-eluting stent, LMS left main stem, LAD left anterior descending, LCx left circumflex, RCA right coronary artery, TIMI thrombolysis in myocardial infarction * indicates significant result
1Wilcoxon rank sum test
2Pearson's Chi-squared test
3Fisher's exact test
4Wilcoxon rank sum exact test
Bold indicate significant result